High-dose influenza vaccines make economic sense for older people

被引：1
|
作者：
Jit, Mark [1 ,2 ]
机构：
[1] Publ Hlth England, Modelling & Econ Unit, London NW9 5EQ, England
[2] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England
来源：
LANCET INFECTIOUS DISEASES | 2015年 / 15卷 / 12期
关键词：
SEASONAL INFLUENZA; VACCINATION; EFFICACY; IMPACT;
D O I：
10.1016/S1473-3099(15)00272-8
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1372 / 1373
页数：2
相关论文
共 50 条
  • [1] High-dose influenza vaccines make economic sense for older people (vol 15, pg 1372, 2015)
    Jit, M.
    LANCET INFECTIOUS DISEASES, 2015, 15 (12): : 1375 - 1375
  • [2] CLINICAL AND ECONOMIC BENEFITS OF ADJUVANTED AND HIGH-DOSE INFLUENZA VACCINES IN THE ELDERLY IN ARGENTINA
    Giglio, N.
    Micone, P., V
    Mould-Quevedo, J.
    Salas, C.
    Montes, J. L.
    Uruena, A.
    VALUE IN HEALTH, 2024, 27 (06) : S85 - S85
  • [3] Canadian older adults' perceptions of effectiveness and value of regular and high-dose influenza vaccines
    Pereira, Jennifer A.
    Gilca, Vladimir
    Waite, Nancy
    Andrew, Melissa K.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (02) : 487 - 495
  • [4] Comparative Safety of Adjuvanted versus High-Dose Inactivated Influenza Vaccines in Older Adults
    Liu, C.
    Schmader, K.
    Harrington, T.
    Roundtree, W.
    Auerbach, H.
    Walter, E.
    Barnett, E.
    Schlaudecker, E.
    Todd, C.
    Ponieweirski, M.
    Staadt, M.
    Wodi, P.
    Broder, K.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 : S140 - S140
  • [5] High-dose influenza vaccine in older adults
    Wang, Joyce M.
    Vardeny, Orly
    Zorek, Joseph A.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2016, 56 (01) : 95 - 97
  • [6] Provider knowledge of trivalent inactivated and high-dose influenza vaccines
    Tewell, Chad
    Wright, Patty W.
    Talbot, H. Keipp
    VACCINE, 2014, 32 (46) : 6025 - 6028
  • [7] Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial
    Schmader, Kenneth E.
    Liu, Christine K.
    Flannery, Brendan
    Rountree, Wes
    Auerbach, Heidi
    Barnett, Elizabeth D.
    Schlaudecker, Elizabeth P.
    Todd, Christopher A.
    Poniewierski, Marek
    Staat, Mary A.
    Harrington, Theresa
    Li, Rongxia
    Broder, Karen R.
    Walter, Emmanuel B.
    IMMUNITY & AGEING, 2023, 20 (01)
  • [8] Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older
    Pillsbury, Alexis J.
    Fathima, Parveen
    Quinn, Helen E.
    Cashman, Patrick
    Blyth, Christopher C.
    Leeb, Alan
    Macartney, Kristine K.
    JAMA NETWORK OPEN, 2020, 3 (05) : E204079
  • [9] Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial
    Kenneth E. Schmader
    Christine K. Liu
    Brendan Flannery
    Wes Rountree
    Heidi Auerbach
    Elizabeth D. Barnett
    Elizabeth P. Schlaudecker
    Christopher A. Todd
    Marek Poniewierski
    Mary A. Staat
    Theresa Harrington
    Rongxia Li
    Karen R. Broder
    Emmanuel B. Walter
    Immunity & Ageing, 20
  • [10] High-Dose Inactivated Influenza Vaccine Quadrivalent for Older Adults
    Chahine, Elias B.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (01) : 89 - 97
12345